Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

This Analyst Just Upgraded ResMed Stock. Here's Why.

ResMed (RMD) shares are pushing higher on Tuesday after a senior RBC Capital Markets analyst upgraded the medical equipment specialist to an “Outperform” rating. In his research note, Craig Wong-Pan cited RMD’s robust Q4 performance as he lifted his price target as well to $262, indicating potential upside of nearly 10% from here.

Note that ResMed stock has already been in a massive uptrend in recent months, currently trading about 28% above its June low.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.